26AP2812 - pluvicto - cleveland VAMC

Active Awarded Last action

Contract number
36C25026N0416
Awardee
Awarding agency
Obligated
$617,297

Award facts

Contract value 100% obligated
$617,296.68 Current and potential, with all options
Completion date 66% complete
Current and potential, with all options
Contracting staff
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
East Hanover, NJ 07936, USA

Award details come from SAM.gov/FPDS.

About this award

Veterans Integrated Service Network 10 issued a $617,296.68 delivery order to Novartis Pharmaceuticals Corporation on July 1, 2026, for PLUVICTO (Lutetium Lu-177 Vipivotide Tetra), a radiopharmaceutical cancer therapy for the Cleveland VAMC, with completion by December 31, 2026.

The order is issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). Place of performance is East Hanover, NJ 07936. This is a firm fixed-price delivery order with no set-aside.

Quick answers

Who was awarded contract 36C25026N0416?

36C25026N0416 was awarded to Novartis Pharmaceuticals Corporation by Veterans Integrated Service Network 10 (Veterans Health Administration) on July 1, 2026.

How much is contract 36C25026N0416 worth?

The government has obligated $617,297 on 36C25026N0416.

Is contract 36C25026N0416 an order under another contract?

Yes. 36C25026N0416 is a delivery order under 36F79720D0180, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C25026N0416 competed?

The extent of competition for 36C25026N0416 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award